Densitas Inc., a leading provider of AI technologies for digital mammography, announced today that its FDA-cleared densitas® densityai™ breast density assessment software will be available on the Nuance® AI Marketplace, which provides access to over 70 percent of all radiologists across the largest network of connected healthcare facilities in the USA.
Densitas densityai™ delivers fully automated, standardized, and reproducible breast density assessments from standard DICOM clinical use images. Density assessments can be incorporated into risk models that evaluate patient-specific breast cancer risk. The AI-powered densitas densityai™ solution is specifically designed to align with how the visual cortex processes images when radiologists visualize mammograms, and rapidly generates reproducible and standardized breast density assessments that line up with the ACR BI-RADS 5th ed. Atlas guidance on interpreting breast density from clinical use mammograms. Densitas recently announced that densitas densityai™ has been selected for use in a major breast screening trial in Germany.
“AI can play an important supporting role for radiologists by automating routine, time-consuming, subjective, and fatiguing tasks so that they can focus on more challenging interpretive tasks,” said Woojin Kim, MD, Chief Medical Information Officer at the Healthcare Division of Nuance Communications. “What sets densitas densityai™ apart is that it has been thoughtfully designed to process routinely archived mammograms so that breast density assessments can be obtained from historical studies when comparing current with prior exams. What I find compelling is that the density results are deeply embedded in the reporting workflow to deliver important information to radiologists at the time of interpretation while automatically populating the report. The densitas densityai™ solution is a welcome addition to the Nuance AI Marketplace, and it represents the high-quality AI solutions that Nuance is bringing together to improve workflow efficiencies and advance patient care.”
“Our presence on the Nuance AI Marketplace makes us readily accessible to over 6,500 connected healthcare facilities,” said Mo Abdolell, CEO of Densitas. “We are excited to see this unique level of workflow integration that supports improved decision making for better patient care and increased reporting efficiency. Mammography is a high-volume reading setting in which breast density must be evaluated and recorded in the final structured report. Visually evaluating and manually recording breast density in a standardized and reproducible way takes more time and distracts from the primary task of cancer detection. Integration of densitas densityai™ results with PowerScribe One and PowerScribe 360 through the Nuance AI Marketplace is a workflow implementation that radiologists will appreciate for its zero-click implementation that delivers standardized and reliably reproducible density results in support of state and federal laws mandating reporting of breast density to women.”
Our vision is to move the needle in breast cancer screening through individualized patient management for sustainable healthcare service delivery. Densitas develops advanced AI-powered solutions that deliver on-demand actionable insights through point-of-care and advanced healthcare analytics for breast health management aimed at improved patient outcomes. The densitasai™ platform, comprising densitas densityai™, densitas qualityai™ and densitas riskai™ tackles pressing challenges facing breast cancer screening today, including precision breast health, mammography quality, workflow efficiencies, compliance with national standards, and meeting accreditation requirements. Learn more at www.densitas.health.